drugset / Trial / NCT00272909

Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)

NCT00272909 ↗

Phase 2 Terminated 43 enrolled Daiichi Sankyo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This research study is designed to evaluate the safety, tolerability, and efficacy of SUN N4057 (piclozotan) in subjects with acute ischemic stroke within 9 hours of the onset of symptoms.

Timeline

Start
2004-09
Primary completion
2006-10
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject piclozotan Small molecule — Intravenous

Indications